Nuclear Regulation INDIGO Biosciences Expands Autoimmune-Focused Preclinical Testing Portfolio – PR Web Carmen Lillard Mar 16, 2021 INDIGO Biosciences expands the portfolio for autoimmune-oriented preclinical tests PR Web